Literature DB >> 3500859

Rapid decrease in lymphocyte adherence to high endothelial venules in lymph nodes deprived of afferent lymphatic vessels.

H R Hendriks1, A M Duijvestijn, G Kraal.   

Abstract

Occlusion of the afferent lymph flow to the lymph node (LN) results in both flattening of the endothelium of high endothelial venules (HEV) and a severe decrease in numbers of lymphocytes in transit across the walls of the flattened HEV. In the present study we have used the in vitro lymphocyte-binding assay to investigate the ability of HEV in rat LN to bind lymphocytes at various time points after occlusion of the afferent lymph flow. In addition the specificity of T and B lymphocyte adherence to HEV of such operated LN was studied. In normal LN, lymphocytes adhered to virtually all HEV using the in vitro binding assay. However, 1 and 2 weeks after operation lymphocytes bound to only 50-60% of the HEV and by 3-6 weeks 20-30%. The total numbers of lymphocytes bound to these HEV had also diminished to 10% of the control value 3-6 weeks after operation. Morphometric analysis showed that this was not only due to a reduction in the area of HEV endothelium available for lymphocyte adherence by flattening of the high endothelial cells, but also to a strong decrease in the numbers of bound lymphocytes per unit area high endothelium. In spite of the reduction in numbers of adhering lymphocytes the T/B cell ratio did not change. The results show that the reduction in lymphocyte binding of HEV in operated LN is a rapid event, probably due to loss of high endothelial cell determinants involved in binding of lymphocytes. The decrease in lymphocyte binding clearly precedes flattening of HEV endothelium suggesting that the height of high endothelial cells is of secondary importance to lymphocyte adherence.

Entities:  

Mesh:

Year:  1987        PMID: 3500859     DOI: 10.1002/eji.1830171203

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

1.  Characterization of high endothelial-like properties of peritubular capillary endothelium during acute renal allograft rejection.

Authors:  R Renkonen; J P Turunen; J Rapola; P Häyry
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

Review 2.  Lymphatic function and immune regulation in health and disease.

Authors:  Shan Liao; Timothy P Padera
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

Review 3.  Lymphocyte migration into mucosal lymphoid tissues: mechanism and modulation.

Authors:  Y H Chin; J P Cai; T Hieselaar
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 4.  Lymph node stromal cells: cartographers of the immune system.

Authors:  Akshay T Krishnamurty; Shannon J Turley
Journal:  Nat Immunol       Date:  2020-03-23       Impact factor: 25.606

5.  Interferon-gamma-increased adherence of lymphocytes to high endothelial venules.

Authors:  H R Hendriks; C Korn; R E Mebius; G Kraal
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

6.  Ultrastructural identification and distribution of the adhesion molecules ICAM-1 and LFA-1 in the vascular and extravascular compartments of the human palatine tonsil.

Authors:  M E Perry; K A Brown; B von Gaudecker
Journal:  Cell Tissue Res       Date:  1992-05       Impact factor: 5.249

7.  Tissue-specific homing receptor mediates lymphocyte adhesion to cytokine-stimulated lymph node high endothelial venule cells.

Authors:  Y H Chin; J P Cai; X M Xu
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

8.  Glycosylation-dependent cell adhesion molecule 1 (GlyCAM 1) mucin is expressed by lactating mammary gland epithelial cells and is present in milk.

Authors:  D Dowbenko; A Kikuta; C Fennie; N Gillett; L A Lasky
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice.

Authors:  S V Onrust; P M Hartl; S D Rosen; D Hanahan
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

10.  CLEC-2 is required for development and maintenance of lymph nodes.

Authors:  Cécile Bénézech; Saba Nayar; Brenda A Finney; David R Withers; Kate Lowe; Guillaume E Desanti; Clare L Marriott; Steve P Watson; Jorge H Caamaño; Christopher D Buckley; Francesca Barone
Journal:  Blood       Date:  2014-02-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.